Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CTMX
FechaHoraFuenteTítuloSímboloCompañía
06/02/201915:41Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:CTMXCytomX Therapeutics Inc
05/02/201907:00GlobeNewswire Inc.CytomX Therapeutics Announces Senior Management AppointmentsNASDAQ:CTMXCytomX Therapeutics Inc
04/02/201909:12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CTMXCytomX Therapeutics Inc
31/01/201915:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
30/01/201907:00GlobeNewswire Inc.CytomX Therapeutics to Host Research and Development Day on February 26, 2019NASDAQ:CTMXCytomX Therapeutics Inc
07/01/201907:00GlobeNewswire Inc.CytomX Therapeutics Announces Technology Acquisition From Agensys, Inc., an Affiliate of Astellas Pharma Inc.NASDAQ:CTMXCytomX Therapeutics Inc
27/12/201811:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
27/12/201811:42Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CTMXCytomX Therapeutics Inc
20/12/201807:00GlobeNewswire Inc.CytomX Therapeutics Announces Changes to its Board of DirectorsNASDAQ:CTMXCytomX Therapeutics Inc
19/11/201812:20Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CTMXCytomX Therapeutics Inc
09/11/201807:00GlobeNewswire Inc.CytomX Therapeutics Presents CX-072 Clinical Translational Data at 2018 SITC Annual MeetingNASDAQ:CTMXCytomX Therapeutics Inc
07/11/201807:00GlobeNewswire Inc.CytomX to Present at the Jefferies 2018 London Healthcare ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
06/11/201815:53Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CTMXCytomX Therapeutics Inc
06/11/201815:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTMXCytomX Therapeutics Inc
06/11/201815:05GlobeNewswire Inc.CytomX Therapeutics Announces Third Quarter 2018 Financial ResultsNASDAQ:CTMXCytomX Therapeutics Inc
06/11/201807:13GlobeNewswire Inc.CytomX Therapeutics Announces CX-072 Clinical Presentations at 2018 SITC Annual MeetingNASDAQ:CTMXCytomX Therapeutics Inc
30/10/201815:03GlobeNewswire Inc.CytomX Therapeutics to Announce Third Quarter 2018 Financial ResultsNASDAQ:CTMXCytomX Therapeutics Inc
22/10/201805:45GlobeNewswire Inc.CytomX Therapeutics Presents Clinical Data from Probody™ Platform and CX-072 at 2018 ESMO Annual MeetingNASDAQ:CTMXCytomX Therapeutics Inc
08/10/201818:24GlobeNewswire Inc.CytomX Therapeutics Announces Presentations at 2018 ESMO Annual MeetingNASDAQ:CTMXCytomX Therapeutics Inc
25/09/201807:00GlobeNewswire Inc.CytomX to Present at Upcoming Healthcare ConferencesNASDAQ:CTMXCytomX Therapeutics Inc
08/08/201815:04GlobeNewswire Inc.CytomX Therapeutics Announces Second Quarter 2018 Financial ResultsNASDAQ:CTMXCytomX Therapeutics Inc
07/08/201815:01GlobeNewswire Inc.CytomX to Present at the 2018 Wedbush PacGrow Healthcare ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
30/07/201815:01GlobeNewswire Inc.CytomX Therapeutics to Announce Second Quarter 2018 Financial ResultsNASDAQ:CTMXCytomX Therapeutics Inc
17/07/201815:01GlobeNewswire Inc.CytomX Therapeutics Announces Closing of Public Offering of Common StockNASDAQ:CTMXCytomX Therapeutics Inc
13/07/201816:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CTMXCytomX Therapeutics Inc
12/07/201818:50GlobeNewswire Inc.CytomX Therapeutics Announces Pricing of Public Offering of Common StockNASDAQ:CTMXCytomX Therapeutics Inc
10/07/201815:01GlobeNewswire Inc.CytomX Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:CTMXCytomX Therapeutics Inc
14/06/201806:30GlobeNewswire Inc.CytomX Announces Appointment of Lloyd A. Rowland Jr. as General CounselNASDAQ:CTMXCytomX Therapeutics Inc
04/06/201808:00GlobeNewswire Inc.CytomX Therapeutics Presents Preliminary Clinical Proof-of-Concept Data from Probody™ Platform and CX-072 at 2018 ASCO Annu...NASDAQ:CTMXCytomX Therapeutics Inc
01/06/201806:30GlobeNewswire Inc.CytomX Announces Conference Call and Webcast to Review PROCLAIM-072 Clinical Data Presentations at the 2018 American Society ...NASDAQ:CTMXCytomX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CTMX